MD, PhD
Associate Clinical Professor Division of Hematology/Oncology, Department of Medicine
University of California, Irvine
As part of IASLC’s Lung Cancer Considered world language series, Dr. Misako Nagasaka hosts this episode in Japanese and reviews important lung cancer data presented at the ASCO 2025 with Dr. Yasushi Goto and Dr. Yuko Oya. Several of the most significant lung cancer trials presented at ASCO are discussed, including CheckMate 816, the NEOADAURA study, the TROPION Lung 02 study, the REZILIENT1 study, and the DeLLphi-304 trial.